Consolidated profit before taxes for three quarters of 2008 of Sanitas AB group was LTL 14.5 m. (€ 4.2 m.), EBITDA totaled to LTL 73.7 m. (€ 21.3 m.). Sales..
MoreTurnover of Vilniaus baldai AB during October 2008 was 14 264 thousand LTL (4 131 thousand EUR), October of previous year – 15 227 thousand LTL (4 410 thousand EUR). Turnover..
MoreAB Invaldos Nekilnojamojo Turto Fondas (INTF), which belongs to the investment company Invalda, signed a contract regarding the sale of the real property at 28 Savanorių Avenue in Vilnius. INTF..
MorePreliminary unaudited sales of Agrowill Group AB for the nine month period ended 30 September 2008 amounted to LTL 39,1 million (EUR 11,3 million). The sales over 9 months of..
MoreAfter inspection of premises of new Sanitas AB plant, National Kaunas City Food and Veterinary Service issued Certificate of Food Management Subject No. 767, granting the right to perform manufacture..
MoreState Medicines Control Agency to the Ministry of Health of Republic of Lithuania (hereinafter – SMCA) inspected Sanitas AB pharmaceutical activity‘s compliance to the requirements of good distribution practice. In..
MoreSanitas AB received the information from its shareholder Invalda AB that it has executed definitive documentation to transfer a 20.3 % interest in Sanitas AB to Baltic Pharma Limited, an..
MoreThe Management Board and major shareholders of Sanitas AB (“Sanitas” or the “Company”) initiated a strategic review in April 2008, to consider various strategic options available to the Company to..
MoreCenter for Drug Administration and Research of U.S. Food and Drug Administration (FDA) after the inspection of sterile pharmaceutical finished dosage manufacturing facility in Polish pharmaceutical company Jelfa SA classified..
More